Chugai Pharmaceutical Co Stock Net Asset
CHGCF Stock | USD 33.27 0.00 0.00% |
Chugai Pharmaceutical Co fundamentals help investors to digest information that contributes to Chugai Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Chugai Pink Sheet. The fundamental analysis module provides a way to measure Chugai Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chugai Pharmaceutical pink sheet.
Chugai |
Chugai Pharmaceutical Co Company Net Asset Analysis
Chugai Pharmaceutical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Chugai Pharmaceutical Net Asset | 1.54 T |
Most of Chugai Pharmaceutical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chugai Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition |
Based on the recorded statements, Chugai Pharmaceutical Co has a Net Asset of 1.54 T. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The net asset for all United States stocks is notably lower than that of the firm.
Chugai Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chugai Pharmaceutical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Chugai Pharmaceutical could also be used in its relative valuation, which is a method of valuing Chugai Pharmaceutical by comparing valuation metrics of similar companies.Chugai Pharmaceutical is currently under evaluation in net asset category among related companies.
Chugai Fundamentals
Return On Equity | 0.29 | |||
Return On Asset | 0.2 | |||
Profit Margin | 0.30 % | |||
Operating Margin | 0.42 % | |||
Current Valuation | 39.67 B | |||
Shares Outstanding | 1.64 B | |||
Shares Owned By Insiders | 59.99 % | |||
Shares Owned By Institutions | 18.71 % | |||
Price To Earning | 19.49 X | |||
Price To Book | 3.95 X | |||
Price To Sales | 0.04 X | |||
Revenue | 999.76 B | |||
Gross Profit | 783.7 B | |||
EBITDA | 419.43 B | |||
Net Income | 303 B | |||
Cash And Equivalents | 545.3 B | |||
Cash Per Share | 331.48 X | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 3.21 X | |||
Book Value Per Share | 865.88 X | |||
Cash Flow From Operations | 279.63 B | |||
Earnings Per Share | 1.71 X | |||
Price To Earnings To Growth | 14.84 X | |||
Number Of Employees | 43 | |||
Beta | 0.52 | |||
Market Capitalization | 44.99 B | |||
Total Asset | 1.54 T | |||
Retained Earnings | 500.19 B | |||
Working Capital | 435.19 B | |||
Current Asset | 542.89 B | |||
Current Liabilities | 107.7 B | |||
Annual Yield | 0.02 % | |||
Net Asset | 1.54 T | |||
Last Dividend Paid | 78.0 |
About Chugai Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chugai Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chugai Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chugai Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Chugai Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chugai Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Chugai Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chugai Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chugai Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chugai Pharmaceutical Co to buy it.
The correlation of Chugai Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chugai Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chugai Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chugai Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chugai Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Chugai Pink Sheet analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |